Αρχική World News 49-Year-Old Breast Cancer Patient Grateful She Didn’t Wait Until 50 for a...

49-Year-Old Breast Cancer Patient Grateful She Didn’t Wait Until 50 for a Mammogram

49-year-old Amy Mason knows how to find the bright side of any situation. But it’s not hard to see the silver lining in this particular cloud. If breast cancer screening guidelines had advised her to start getting checked at 50 instead of 40, her cancer wouldn’t have been detected until at least a year later.As it was, however, doctors were able to see the change in her tissue between her two latest 3D mammograms and know that something wasn’t quite right. The single mother of three got her diagnosis in time, and her condition is very treatable. If she had waited, the aggressive triple-negative cancer might have progressed much further without her knowledge.Photo: WTVR 6How early and how often women should get mammograms has been a widely debated topic in recent years, with some experts recommending yearly mammograms, while others suggest bi-yearly screening, and some guidelines suggesting a starting age of 40 while others say 50. The American Society of Breast Surgeons currently believes 40 is the optimal age to start getting mammograms, and that recommendation may have saved Amy Mason’s life.
Photo: WTVR 6“If I would have waited, it probably would have had metastasized to other places and been a very sick person,” she says.That, of course, doesn’t change the shock that any cancer diagnosis will give you. “It’s like a punch. A hard punch. You can’t breathe,” recalls Amy.Once a week, Amy travels from North Carolina to the VCU Massey Cancer Center in Virginia for her chemotherapy treatment. Now that the shock of the diagnosis has worn off, Amy has continued to find humor in just about everything, including the wig she got after losing her hair to cancer treatment. She calls it Leslie and treats it more or less like a member of the family.
Photo: WTVR 6“We’ll be getting ready to go and I’ll say ‘Somebody go get Leslie. She’s got to go with us,’” says Amy. “I have a great wig.”For those interested in the American Society of Breast Surgeons‘s guidelines on breast cancer screening, here are the main points:1. Women over 25 should undergo a formal risk assessment for breast cancer.
2. Women with an average risk of breast cancer should initiate yearly screening mammography at age 40.
3. Women with a higher-than-average risk of breast cancer should undergo yearly screening mammography and be offered yearly supplemental imaging; this screening should be initiated at a risk-based age.
4. Screening mammography should cease when life expectancy is less than 10 years.

Photo: WTVR 6Dr. Kandace McGuire, chief of breast surgery at Massey, says the new guidelines have resulted in a 15 percent reduction in mortality. She still stresses, however, that deciding which set of guidelines to follow is a patient’s choice and can be very personal.Amy is still battling stage III breast cancer and has more chemo and surgery ahead of her, but she’s grateful for her life and is doing her best to have fun, no matter what happens. “Enjoy every moment and appreciate the little things,” she says.Check out the video below to learn more about Amy’s spectacularly positive attitude and how the guidelines from the American Society of Breast Surgeons changed her life.Proper BCS greatergood_ctg_abovevideoSource

NEWSLETTER

Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like
57ΑκόλουθοιΑκολουθήστε

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...

ΠΑΓΚΟΣΜΙΑ ΗΜΕΡΑ ΚΑΡΚΙΝΟΥ

Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ)

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

Despite Proven Safety of HPV Vaccines, More Parents Have Concerns

October 22, 2021, by NCI Staff Credit: National Cancer Institute Despite more than 15 years of consistent evidence that HPV vaccines are safe and effective, a...

FDA Approves Atezolizumab as Adjuvant Treatment for Non-Small Cell Lung Cancer

On 15 October 2021, the US Food and Drug Administration (FDA) approved atezolizumab (Tecentriq, Genentech, Inc.) for adjuvant treatment following resection and platinum-based chemotherapy...

Breast Cancer Survivor Uses Comedy to Spread Awareness and Address Disparities

Suzette Simon lost her mother to breast cancer. In 2020, she learned that she had the disease, as well. Realizing how much harder breast...

Why Wearing Comfortable Clothes During Cancer Treatment Matters

Voices on Cancer is an award-winning Cancer.Net Blog series where advocates share their stories and the lessons they have learned about being a cancer advocate. Cindy Trice is...

Breast cancer surgery: ‘I’m proud of the tattoos inked across my chest’

Wendy had a double mastectomy in 2017 and remained flat. “When the consultant told me, I remember crying and saying that I have 2 young...

EMA Recommends Granting a Marketing Authorisation for Zanubrutinib for the Treatment of Waldenström’s Macroglobulinaemia

On 16 September 2021, the European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use adopted a positive opinion, recommending the granting of...